Drug Profile
GO 7852
Alternative Names: GOE 7852Latest Information Update: 24 Jan 2007
Price :
$50
*
At a glance
- Originator Goedecke
- Class Antineoplastics
- Mechanism of Action Protein kinase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 06 Nov 1997 No-Development-Reported for Cancer in Germany (Unknown route)
- 10 Nov 1995 Preclinical development for Cancer in Germany (Unknown route)